Gilead Tenofovir Cases, Gilead Sciences v. Superior Court of the City and County of San Francisco

| February 24, 2025

(Ca., filed November 4, 2024): Arguing that the novel duty to innovate recognized by the Court of Appeal would flood the judiciary and burden manufacturers with a large number of speculative lawsuits and would undermine the predictability of product liability law. Additionally, the new duty would result in price increases as manufacturers tried to estimate the magnitude of their potential liability and would slow the pace of innovation and undermine safety in the name of promoting it.

Case not yet decided

Alarming Expansion in Public Nuisance Litigation Revealed by ATRA Report

Press Releases

From Social Media to Car Thefts, New Litigation Trends Threaten Entire Industries

Georgia Legislature Passes Landmark Tort Reform Bill

Press Releases

ATRA Applauds Passage, Anticipates Governor’s Signature on SB 68

The trial lawyer playbook: How aggressive advertising and junk science are costing Californians

In The News

In 2024, legal services ads hit $164 million in LA, part of a 39% national rise, fueling aggressive marketing, third-party funding, and straining California’s economy and courts.